Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arcutis Biotherapeutics (ARQT) Leases (2020 - 2025)

Arcutis Biotherapeutics has reported Leases over the past 6 years, most recently at $4.5 million for Q4 2025.

  • Quarterly results put Leases at $4.5 million for Q4 2025, up 128.73% from a year ago — trailing twelve months through Dec 2025 was $4.5 million (up 128.73% YoY), and the annual figure for FY2025 was $4.5 million, up 128.73%.
  • Leases for Q4 2025 was $4.5 million at Arcutis Biotherapeutics, down from $4.6 million in the prior quarter.
  • Over the last five years, Leases for ARQT hit a ceiling of $4.6 million in Q3 2025 and a floor of $1.7 million in Q2 2025.
  • Median Leases over the past 5 years was $2.7 million (2022), compared with a mean of $2.8 million.
  • Biggest five-year swings in Leases: skyrocketed 1346.46% in 2021 and later dropped 20.11% in 2025.
  • Arcutis Biotherapeutics' Leases stood at $3.0 million in 2021, then decreased by 10.49% to $2.7 million in 2022, then dropped by 13.23% to $2.4 million in 2023, then decreased by 17.28% to $2.0 million in 2024, then skyrocketed by 128.73% to $4.5 million in 2025.
  • The last three reported values for Leases were $4.5 million (Q4 2025), $4.6 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.